The Impact of COVID-19 on Adolescents with Eating Disorders: A Cohort Study

doi:10.21203/rs.3.rs-232482/v1

Download PDF

Research article

The Impact of COVID-19 on Adolescents with Eating Disorders: A Cohort Study

https://doi.org/10.21203/rs.3.rs-232482/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background: There is a noticeable lack of evidence regarding the impact of COVID-19 and the associated lockdown on young people with eating disorders. The goals of this study were 1) to examine characteristics of adolescents presenting for eating disorder (ED) assessment since the onset of the COVID-19 pandemic; 2) to compare adolescents presenting for ED assessment since the onset of the COVID-19 pandemic to those that presented for assessment one year previously; 3) to examine implications of the pandemic on the system of care.

Methods: A retrospective chart review was completed on all patients assessed at a pediatric tertiary care ED program during the pandemic between April 1 and October 31, 2020, and on youth assessed during the same time frame one year previously. Data including body measurements and results of psychological measures was extracted from patients’ charts. Clinician reports were utilized for accounts of ED symptoms. Referrals to our program were also compared for the two time periods.

Results: Of the 48 youth assessed between April and October 2020, average age was 14.6 years and average percentage of treatment goal weight was 77.7%. 40% cited the pandemic as a trigger for their ED; of these youth, 78.9% were medically unstable compared to 55.2% of those whose ED was not triggered by the pandemic. When comparing the 2020 cohort to those assessed in 2019, youth who presented for assessment during the pandemic trended towards having lower percentage of goal weights and higher rates of self-reported impairment, and were significantly more likely to be medically unstable and to require hospitalization. Higher rates of inpatient admissions, emergency room consultation requests and outpatient referrals deemed “urgent” were likewise associated with the pandemic period.

Internal Medicine

Eating disorders

anorexia nervosa

adolescent

COVID-19

pandemic

cohort study

The objective of this study was to examine characteristics of adolescents presenting for eating disorder (ED) assessment during the COVID-19 pandemic, and also to compare them to a similar group assessed one year previously. A review of medical charts was completed on patients assessed at a pediatric ED program between April 1 and October 31, 2020 and on patients assessed between April 1 and October 31, 2019. 48 adolescents were assessed during the pandemic-specific timeframe and 43 were assessed during the same timeframe the year previously. Forty percent of those in the 2020 cohort cited pandemic effects as a trigger for their ED; these youth had a shorter course of illness and were somewhat more likely to be medically compromised compared to those whose ED was not triggered by the pandemic. Compared to those seen in 2019, adolescents assessed for an ED in 2020 exhibited higher rates of nutritional restriction and functional impairment, were significantly more likely to be medically unstable, and required more hospitalizations or urgent consultations. Further research is required to better understand the impact of COVID-19 on the clinical course and outcomes of EDs in youth.

Since being declared a global pandemic on March 11, 2020 (World Health Organization, 2020) the coronavirus disease 2019 (COVID-19) has introduced risk to health, caused economic disruption, and affected future planning, and has led countries to implement various social restrictions including lockdowns, school closures, and “physical distancing” to contain the progression of the virus. The inevitable impact on mental health (MH) has been identified as an urgent clinical and research priority. This holds true especially for youth, for whom unique developmental challenges render them particularly vulnerable to the effects of school closures and disrupted peer contact (Holmes et al., 2020). Despite early translation of knowledge regarding the role of COVID-19 on adult MH, few studies have examined the impact in children and youth (Racine et al., 2020). Canadian data suggests that 61% of Ontario youth (12–25) have reported a worsening of their general MH during the pandemic (Radomski et al., 2020). In a survey of 622 Canadian youth, Hawke et al. (2020) reported significant deterioration of mental health during the pandemic, with 68.4% of youth in the clinical sample and 39.9% in the community sample meeting criteria for an internalizing disorder. Further, female participants, as well as those receiving MH services prior to the onset of the pandemic, have been shown to be at increased risk (Oosterhoff et al., 2020; Radomski et al., 2020; Zhou et al., 2020).

In addition to the paucity of research involving the effect of the pandemic on the MH of children and youth, there is a noticeable lack of evidence regarding the impact of COVID-19 on children and youth with eating disorders (EDs). Initial research suggested that almost half of adolescents with EDs reported a reactivation of symptoms of restricting and over-exercising and fear of weight gain during the pandemic (Graell et al., 2020). Evolving literature also suggests that many adults with pre-existing EDs report a worsening of ED symptoms during the pandemic (Castellini et al., 2020; Phillipou et al., 2020; Schlegl, Maier, et al., 2020; Schlegl, Meule, et al., 2020; Termorshuizen et al., 2020). Questions remain during these unprecedented times as we examine the impact of the pandemic and lockdown on new-onset cases. What is the effect on youth of the cessation of school, social contact and extracurricular activities? Does the COVID-19 health risk and associated media coverage within our communities increase anxiety in vulnerable youth? Does any of this trigger EDs in young people, or affect the course of illness?

Our tertiary care pediatric ED program is located in a large Canadian city that experienced significant restrictions and closures from March 17th to July 5th, 2020. In addition to school closures, non-essential workplaces, businesses, recreation facilities and outdoor spaces and parks were closed during this time. While strict lockdown regulations lifted temporarily after this 4-month period, ongoing limitations and the resultant psychosocial stress due to COVID remained in effect within our region. Limited knowledge exists as to how these restrictions have affected patients and families at-risk or living with an ED, or how effects of the pandemic may have affected the system of care available to treat these individuals.

The objective of this study is to better understand the impact of COVID-19 on a tertiary care center for pediatric eating disorders. Our aim was threefold; i) to describe presenting characteristics at initial assessment of a cohort of youth accessing care during the pandemic lockdown and to compare and contrast those citing the pandemic as an ED trigger from those who did not; ii) to distinguish the cohort of youth presenting during the pandemic from a separate cohort of youth who had presented during the same time frame one year previously (seeking to understand the effects of COVID-19 on patient characteristics and illness presentation); and iii) to examine and describe programmatic implications of the pandemic on referral patterns and rates of hospitalization.

Participants and Procedure

Our multidisciplinary intensive ED program is located in a Canadian tertiary care children’s hospital. Individuals meeting criteria for an intake assessment in the program are children and adolescents aged 9 to 17 years with severe EDs (as evidenced by concerns regarding medical stability, growth compromise, symptom-severity or acute safety concerns relating to ED presentation) who are referred by a physician. Data from all patients who were sequentially assessed in our program between April 1-October 31, 2019 and between April 1-October 31, 2020 were included in this study. A retrospective chart review was completed of initial multi-disciplinary assessment notes (completed by Adolescent Health physicians, psychiatrists, psychologists, and/or dieticians on the Eating Disorder team) and of accompanying self-report questionnaires collected as part of the intake process. Data gathered was de-identified and stored in an electronic database for analysis. Informed consent for use of this data was sought as part of the standardized intake process. This study was approved by the Research Ethics Board at the hospital where the research was conducted. The data that support the findings of this study are not publicly available due to privacy and ethical concerns, but can be provided upon request to the corresponding author.

Measures

Demographic and Clinical Characteristics

Data regarding various demographic, clinical, and treatment related characteristics were extracted from patients’ electronic charts based on information found in the clinician’s initial intake assessment notes, using both patient and caregiver reports. Details regarding body measurements were also recorded, and in all cases, patient’s premorbid growth trajectory (including available height, weight, and body mass index) was utilized to help determine the patient’s treatment goal weight (TGW) (Norris et al., 2018). Reliance on clinician-report for accounts of eating behaviours as well as ED symptoms was utilized.

Eating Behaviours and Cognitions

Eating Disorder Examination Questionnaire for Adolescents (EDEQ-A). The EDEQ-A is a self-report questionnaire with 36 items that examines eating related cognitions and behaviours. The scale produces a global score and four subscale scores (Restraint, Eating Concern, Shape Concern, and Weight Concern) along with asking questions related to frequency of common ED behaviours (vomiting, diuretic use, laxative use, compulsive exercise). The EDEQ-A has been found to have strong psychometric properties in adolescent samples (Carter et al., 2001).

Children’s Eating Attitudes Test (chEAT). Adapted from the Eating Attitudes Test (EAT; Garner & Garfinkel, 1979), the ChEAT is a 26-item measure featuring simpler language for use in children and adolescents aged 8 to 13 years. The chEAT has adequate internal reliability, good concurrent validity, and a factor structure that is similar to the original EAT (Smolak & Levine, 1994).

Clinical Impairment Assessment Questionnaire (CIA). The CIA is a brief, 16-item self-report measure that assesses the impact of ED psychopathology on an individual’s functioning. The CIA has high levels of internal consistency and test-retest reliability, and is positively correlated with scores on the EDE-Q, indicating good construct validity (Bohn et al., 2008).

Psychological Comorbidities

Revised Children’s Anxiety and Depression Scale (RCADS). The RCADS is a 47-item self-report questionnaire that assesses anxiety and depression in youth. In addition to generating a Total Anxiety Score and Total Internalizing Score, the RCADS also produces total scores for separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and major depressive disorder. A t-score ≥65 indicates that a score is in the 93^rd percentile of normative data (borderline clinical range), while a score ≥70 indicates that a score is in the 98^th percentile (clinical range). The RCADS has been found to have good psychometric properties and a factor structure consistent with DSM-IV depression and anxiety disorders (Chorpita et al., 2000).

Analytic Plan

Descriptive and frequency statistics were performed to examine distributions and describe the clinical characteristics across all samples. Independent sample t-tests with a Welch correction were used when appropriate to compare characteristics across groups for continuous variables. Chi-square analyses were used to examine differences across categorical variables. Relationships with a relaxed p-value of less than 0.10 were also examined in this study given the clinical nature of this work and the small sample size available to start to explore these relationships (Thiese, Ronna, Ott, 2016). Cohen’s d was used to examine effect sizes, with 0.2 considered a small effect, 0.5 considered a moderate effect and 0.8 or greater a large effect (Cohen, 1988). All analyses were performed using IBM SPSS v.26.

Pandemic cohort

A total of 48 adolescents were assessed during the pandemic-specific timeframe (April 1, 2020 to Oct 31, 2020). These youth were on average 14.6 years (SD = 1.79, range = 9.96–17.83), primarily female (83.3%), and most were diagnosed with DSM-5 anorexia nervosa (AN; see Table 1). Individuals at assessment were on average 77.7% of their treatment goal weight (TGW; SD = 9.21, range = 54.67 to 100%) with 64.6% of patients deemed medically unstable at presentation (with medical instability defined as: heart rate less than 45 beats per minute; blood pressure less than 90/50; TGW < 75%; abnormalities in extended electrolytes; or, end organ dysfunction). While the majority of patients (97.9%) presented with nutritional restriction as their primary ED symptom, 27 (56.2%) also reported over-exercising, and a minority reported bingeing or purging behaviours (18.8% and 20.8%, respectively).

Of the 48 patients assessed during the pandemic-specific timeframe, 40% (n=19) cited COVID-19 as a precipitating factor to their ED. The clinical characteristics of these 19 patients were compared to the 29 youth who did not identify the pandemic as a trigger for their ED (see Table 2). Among all variables examined, a significant difference between groups was detected only for self-reported duration of symptoms since disease onset. On average those with a COVID-triggered ED reported symptoms for less than 6 months (M=5.59, SD=3.75) prior to formal ED assessment, while those without COVID related triggers had experienced symptoms for just less than one year (M=11.63 months, SD=9.09) before presentation for assessment (t₍₃₈₎=2.87, p=.007, d=0.82).

However, approaching significance in comparison between the two groups was the difference in medical status at presentation, with 78.9 % (n=15/19) of those with a COVID-related trigger being medically unstable at assessment, compared to 55.2% (n=16/29) of those with a non-COVID related onset (χ(1)=2.84, p=0.09), suggesting a trend towards a steeper decline in health for those patients whose ED was triggered by pandemic-related factors. Also trending towards statistical significance was the BMI at which patients presented, whereby those in the COVID-triggered group presented with an average BMI of 16.74 kg/m² while those in the non-COVID group presented with an average BMI of 18.41 kg/m² (t₍₄₆₎=1.81, p=.076, d=0.53).

Annual-based Cohort Comparisons

To better understand any potential impact of the pandemic on the cohort of individuals who presented from April 1^st to October 31st, 2020 (n=48), comparisons were conducted on a sample of 43 youth sequentially assessed during the same time frame but from the previous year, namely April 1 to October 31, 2019 (see Table 2). Average age for this sample was 14.97 years (SD=1.62), most were female (n=32; 74.4%) and diagnosed with anorexia nervosa (67.5%), and average percentage of TGW at assessment was 81%. Comparisons between the two cohorts yielded several trends approaching statistical significance (p<.10). Those in the 2020 ‘pandemic’ cohort presented with lower average %TGW (77%) than those assessed the year previously (%TGW=81%; t(62)=1.85, p=.070, d=.96). Those in the COVID group also reported higher levels of functional impairment on the CIA as a result of their ED symptoms (M=30.6, SD= 13.69) compared to those presenting in the preceding year (M=24.0, SD=15.88; t(60)=-1.68, p=.098, d=.44). Finally, those in the COVID group reported higher levels of eating restraint (ie restricting intake) (M=4.00, SD=1.78) on the EDEQ-A than those presenting in 2019 (M=2.72, SD=2.12; t(62)=-1.90, p=.065, d=.63). When examining medical status, those who presented for assessment during the pandemic were on average significantly more medically unstable (n=31/48, 64.6%) than those who presented in 2019 (n=15/43, 34.9%; (χ(1)=8.00, p=0.005). When comparing rates of hospitalization between the groups, 41.9% (n=18/43) of patients assessed in 2019 required admission within 4 weeks of assessment whereas 70.8% (n=34/48) of patients assessed in 2020 required admission within 4 weeks of assessment (χ(1)=7.77, p=0.005). For the 2020 cohort, 84.2% of the 19 patients who cited the pandemic as a trigger for their ED required admission to hospital within 4 weeks of assessment, while 62.1% of the other 29 patients from 2020 required an admission within the month.

Programmatic Effects of COVID

In addition to the unique challenges the pandemic has presented to individuals and their families with EDs, the pandemic has also affected the system of care available to serve youth with EDs. Most notably, perhaps partly as a result of many community supports being closed due to the lockdown, the intensive program at our tertiary care center experienced a surge of 63% in youth requiring inpatient treatment (67 patients in 2020 compared to 41 patients in 2019). Some of these patients were new cases, while others were patients who relapsed during the time of the pandemic. There was also a 28% increase in young people with EDs who required assessment in the emergency room during the pandemic period as compared to the previous year. Outpatient referrals during the pandemic revealed a 56% increase in youth being referred for needs deemed by their community providers to be “urgent” (22/95 in 2019 compared to 28/78 in 2020).

Despite a small emerging body of literature that seeks to better understand how the COVID-19 pandemic has affected clinical and symptom presentation in adolescent patients with established EDs, we are unaware of any published study that has examined variables that investigate how the pandemic has impacted new ED illness presentations in adolescents and that has also examined the impact on the system of care available to provide treatment to these young people. As summarized by Fernandez-Aranda et al., a variety of possible precipitating factors related to the COVID-19 pandemic might contribute to the development of an ED in vulnerable individuals. Examples include increased isolation and loneliness that can occur as a consequence of restrictions, maladaptive coping as a consequence of increased confinement and stress, greater time spent on social-media, and over-evaluation of the thin ideal (Fernández-Aranda et al., 2020). In addition, given the normative developmental period of adolescence whereby greater reliance is placed on peer versus family relations, the effects of the restrictions of the pandemic, including isolation from peers, are likely to be heightened and particularly harmful. Similarly, for adolescents whose sense of self may be entwined with their participation in sport, the cancellation of extra-curricular and sports activities may pose a developmental struggle that may trigger or exacerbate eating disorder symptoms.

Regardless of the unique potential contributors, our study affirms that many patients (40%) assessed in the months that followed the COVID-19 associated lockdown cited the pandemic as a direct trigger for their illness onset. Further, our study suggests that those who cited the effects of the pandemic as a trigger for their ED experienced a more acute onset of their illness (duration of illness 5.59 months vs 11.63 months) and were more medically compromised at the time of presentation (78.9% medically unstable and 84.2% requiring hospitalization) than those who did not cite the pandemic as a trigger (55.2% medically unstable and 62.1% requiring hospitalization). Although those from the 2020 cohort with a COVID-related ED onset presented with the same level of symptomatology and distress (or more) as those with a non-COVID related ED, they deteriorated to that stage at a faster rate than those who did not report COVID as a trigger.

Compared to patients who were assessed in 2019, youth from the 2020 ‘pandemic’ cohort who presented for initial assessment demonstrated differences in medical status as manifested by significantly higher rates of medical instability. These youth had greater need for inpatient admission. In addition to presenting with increased medical morbidity, those in the pandemic cohort presented with higher levels of ‘restraint’ (restricting intake) and higher levels of functional impairment as a result of their ED symptoms when compared to the cohort assessed the year previously. We speculate that the increased impairment, increased medical instability and increased need for hospitalization in the 2020 cohort may have been influenced by such factors as youth having more unstructured spare time during the pandemic lockdown, increased social media and screen time, isolation and loss of peer supports, loss of sports and extra-curricular activities, and disruption in normative developmental processes, along with increased desire to regain a sense of control given the loss of structure (school and extra-curricular activities) and loss of social interactions due to the pandemic. It is also possible that some families may have initially avoided taking their children to hospital for treatment of an ED due to fears of infection, while others may have had more difficulty accessing care during the shutdown.

The impact of the pandemic on the system of care available to treat these youth was also quite significant, with the need for inpatient admissions increased by 63% from the same time period the year before, putting strain on team resources and on hospital bed flow and capacity. This trend in medical morbidity at the time of presentation for assessment during the pandemic was further illustrated by the increased number of acute assessment requests from our Emergency Department, as well as the number of outpatient referrals deemed urgent.

Strengths of the present study include our findings relating to the impact of the COVID-19 lockdown on ED presentation in children and youth. Limitations of the present paper include its retrospective design, small sample size and limited power to detect statistically significant differences. Additionally, our use of self-report psychological measures and the lack of standardized clinical interviews limit the generalizability of our findings. In addition to these limitations, the lockdown restrictions also disrupted many regular hospital-based procedures, including standardized processes for administration of self-report questionnaires, which for our team would typically involve the use of an online questionnaire system with an embedded consent process for secondary use of data. The early lockdown restrictions limited not only in-person staff to deliver the online questionnaire system, but also forced the return to paper-and-pencil questionnaires to limit sharing of devices amongst patients. This change had an immediate effect on the sample size attained for this study, as there were a number of patients who completed paper-and-pencil questionnaires but then did not have the opportunity to provide consent for use of data, given the shift in regulatory process.

Although more research is clearly required, our findings begin to inform our understanding of the manner and complexity by which the pandemic and subsequent lockdown affects ED presentations in adolescents, and highlights the importance of monitoring and treating this population during a time when services may be limited. Moving forward, it will be important for research teams to work collaboratively using validated and prospective designs to better understand how COVID-19 factors impact not only illness presentation but also short- and long- term outcomes of EDs in youth.

The pandemic and subsequent lockdown poses a significant risk for triggering EDs in young people. Youth who present for an assessment of an eating disorder during the COVID-19 pandemic exhibit high rates of medical compromise and may require close medical monitoring, which may be more challenging during the pandemic, when access to care can be limited. Further research is required to better understand how the effects of the pandemic contribute to ED illness onset and presentation, as well as to understand the trajectory and outcomes of pandemic-triggered EDs in adolescents.

Ethics approval and consent to participate:

This study was approved by the Research Ethics Board at the hospital where the research was conducted (Children’s Hospital of Eastern Ontario, Ottawa, Canada). Informed consent for use of the data in this study was sought as part of the standardized intake process. Data gathered was de-identified and stored in an electronic database for analysis.

Consent for publication:

The manuscript has not been simultaneously submitted or published elsewhere.

Availability of supporting data:

The data that support the findings of this study are not publicly available due to privacy and ethical concerns, but can be provided upon request to the corresponding author (WS).

Competing interests:

None of the authors have any competing interests or conflicts of interest.

Funding:

This research is part of our program evaluation, and as such we received no external funding for this study.

Authors’ Contributions:

WS developed the initial idea for this study and WS, MN and NO were major contributors in writing the manuscript. NO and ME analyzed the data, performed the statistics and created the tables. ME helped with writing the original draft of the manuscript and with formatting the paper. NF, SF, MH, LI, SF, MN, AR and NF all treated and/or assessed the patients involved in this study. All authors have contributed to, reviewed and approved this manuscript for submission.

Acknowledgements:

N/A

Bohn, K., Doll, H. A., Cooper, Z., O’Connor, M., Palmer, R. L., & Fairburn, C. G. (2008). The measurement of impairment due to eating disorder psychopathology. Behaviour Research and Therapy, 46(10), 1105–1110. https://doi.org/10.1016/j.brat.2008.06.012
Carter, J. C., Stewart, D. A., & Fairburn, C. G. (2001). Eating disorder examination questionnaire: norms for young adolescent girls. Behaviour Research and Therapy, 39(5), 625–632. https://doi.org/10.1016/s0005-7967(00)00033-4
Castellini, G., Cassioli, E., Rossi, E., Innocenti, M., Gironi, V., Sanfilippo, G., Felciai, F., Monteleone, A. M., & Ricca, V. (2020). The impact of COVID-19 epidemic on eating disorders: A longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls. International Journal of Eating Disorders, May, 1–8. https://doi.org/10.1002/eat.23368
Chorpita, B. F., Yim, L., Moffitt, C., Umemoto, L. A., & Francis, S. E. (2000). Assessment of symptoms of DSM-IV anxiety and depression in children: A revised child anxiety and depression scale. Behaviour Research and Therapy, 38(8), 835–855. https://doi.org/10.1016/s0005-7967(99)00130-8
Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Academic Press. https://doi.org/10.4324/9780203771587
Fernández-Aranda, F., Casas, M., Claes, L., Bryan, D. C., Favaro, A., Granero, R., Gudiol, C., Jiménez-Murcia, S., Karwautz, A., Le Grange, D., Menchón, J. M., Tchanturia, K., & Treasure, J. (2020). COVID-19 and implications for eating disorders. European Eating Disorders Review, 28(3), 239–245. https://doi.org/10.1002/erv.2738
Garner, D. M., & Garfinkel, P. E. (1979). The Eating Attitudes Test: An index of the symptoms of anorexia nervosa. Psychological Medicine, 9(2), 273–279. https://doi.org/10.1017/S0033291700030762
Graell, M., Morón-Nozaleda, M. G., Camarneiro, R., Villaseñor, Á., Yáñez, S., Muñoz, R., Martínez-Núñez, B., Miguélez-Fernández, C., Muñoz, M., & Faya, M. (2020). Children and adolescents with eating disorders during COVID-19 confinement: Difficulties and future challenges. European Eating Disorders Review, June, 1–7. https://doi.org/10.1002/erv.2763
Gratz, K. L., & Roemer, L. (2004). Multidimensional Assessment of Emotion Regulation and Dysregulation: Development, Factor Structure, and Initial Validation of the Difficulties in Emotion Regulation Scale. Journal of Psychopathology and Behavioral Assessment, 26(1), 41–54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94
Holmes, E. A., O’Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., Ford, T., John, A., Kabir, T., King, K., Madan, I., Michie, S., Przybylski, A. K., Shafran, R., Sweeney, A., … Bullmore, E. (2020). Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry, 7(6), 547–560. https://doi.org/10.1016/S2215-0366(20)30168-1
Norris, M. L., Hiebert, J. D., & Katzman, D. K. (2018). Determining treatment goal weights for children and adolescents with anorexia nervosa. Paediatrics & Child Health, 23(8), 551–551. https://doi.org/10.1093/pch/pxy133
Oosterhoff, B., Palmer, C. A., Wilson, J., & Shook, N. (2020). Adolescents’ Motivations to Engage in Social Distancing During the COVID-19 Pandemic: Associations With Mental and Social Health. The Journal of Adolescent Health, 67(2), 179–185. https://doi.org/10.1016/j.jadohealth.2020.05.004
Phillipou, A., Meyer, D., Neill, E., Tan, E. J., Toh, W. L., Van Rheenen, T. E., & Rossell, S. L. (2020). Eating and exercise behaviors in eating disorders and the general population during the COVID-19 pandemic in Australia: Initial results from the COLLATE project. International Journal of Eating Disorders, 53(7), 1158–1165. https://doi.org/10.1002/eat.23317
Racine, N., Cooke, J. E., Eirich, R., Korczak, D. J., McArthur, B. A., & Madigan, S. (2020). Child and adolescent mental illness during COVID-19: A rapid review. Psychiatry Research, 292. https://doi.org/10.1016/j.psychres.2020.113307
Radomski, A., Cloutier, P., Gardner, W., Pajer, K., Sheridan, N., Sundar, P., & Cappelli, M. (2020). Planning for the mental health surge: The self-reported mental health impact of COVID-19 on young people and their needs and preferences for future services. 1–36.
Schlegl, S., Maier, J., Meule, A., & Voderholzer, U. (2020). Eating disorders in times of the COVID-19 pandemic—Results from an online survey of patients with anorexia nervosa. International Journal of Eating Disorders, 53(11), 1791–1800. https://doi.org/10.1002/eat.23374
Schlegl, S., Meule, A., Favreau, M., & Voderholzer, U. (2020). Bulimia nervosa in times of the COVID-19 pandemic—Results from an online survey of former inpatients. European Eating Disorders Review, 28(6), 847–854. https://doi.org/10.1002/erv.2773
Smolak, L., & Levine, M. P. (1994). Psychometric Properties of the Children’s Eating Attitudes Test. International Journal of Eating Disorders, 16(3), 275–282. https://doi.org/10.1002/1098-108x(199411)16:3<275::aid-eat2260160308>3.0.co;2-u
Termorshuizen, J. D., Watson, H. J., Thornton, L. M., Borg, S., Flatt, R. E., MacDermod, C. M., Harper, L. E., van Furth, E. F., Peat, C. M., & Bulik, C. M. (2020). Early impact of COVID-19 on individuals with self-reported eating disorders: A survey of ~1,000 individuals in the United States and the Netherlands. International Journal of Eating Disorders, 53(11), 1780–1791. https://doi.org/10.1002/eat.23353
Thiese, M.S., Ronna, B., & Ott, U. (2016). P value interpretations and considerations. Journal of Thoracic Disease, 8(9), E928-E931. https://doi.org/10.21037/jtd.2016.08.16
World Health Organization. (2020). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus. World Health Organization. https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
Zhou, S. J., Zhang, L. G., Wang, L. L., Guo, Z. C., Wang, J. Q., Chen, J. C., Liu, M., Chen, X., & Chen, J. X. (2020). Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. European Child and Adolescent Psychiatry, 29(6), 749–758. https://doi.org/10.1007/s00787-020-01541-4

Table 1

Demographic and clinical characteristics for patients assessed between April 1 and October 31 in 2019 and 2020.
	2019 (n = 43)	2020 (n = 48)
		COVID-triggered ED (n = 19)	Non COVID-triggered ED (n = 29)
Age	14.97 (1.62)	14.23 (1.82)	14.84 (1.76)
BMI	18.12 (2.92)	16.74 (2.42)^a	18.41 (3.50)^b
Gender
Female	32 (74.4%)	14 (73.7%)	26 (89.7%)
Male	10 (23.3%)	4 (21.1%)	1 (3.4%)
Trans Female	0 (0%)	0 (0%)	1 (3.4%)
Trans Male	1 (2.3%)	1 (5.3%)	1 (3.4%)
Diagnosis
AN restrictive	26 (60.5%)	13 (68.4%)	11 (37.9%)
AN binge-purge	3 (7.0%)	2 (10.5%)	5 (17.2%)
ARFID	7 (16.3%)	2 (10.5%)	5 (17.2%)
Atypical AN	3 (7.0%)	2 (10.5%)	4 (13.8%)
BN	0 (0%)	0 (0%)	1 (3.4%)
UFED	2 (4.7%)	0 (0%)	3 (10.3%)
Other	2 (4.7%)	0 (0%)	0 (0%)
Medically unstable at assessment	15 (34.9%)^aa	15 (78.9%)^b	16 (55.2%)^c
Inpatient admission within 4 weeks of assessment	18 (41.9%)^aa	16 (84.2%)^b	18 (62.1%)^c
Restriction	42 (97.7%)	19 (100.0%)	28 (96.6%)
Over-exercise	20 (46.5%)	14 (73.7%)^a	13 (44.8%)^b
Bingeing (last 4 weeks)	3 (7.0%)	3 (15.8%)	6 (20.7%)
Purging (last 4 weeks)	1 (2.3%)^aa	2 (10.5%)	8 (27.6%)

Notes. Data are expressed as mean (SD) or n (%). AN, anorexia nervosa; ARFID, avoidant restrictive food intake disorder; BN, bulimia nervosa; UFED, unspecified feeding and eating disorder.

Superscripts denote statistically significant differences at the ^xp < .10, ^xxp < .001

Table 2

Comparisons across patients assessed in 2019 versus patients assessed in 2020.
	n	2019 Patients	n	2020 Patients	t-test (p-value)	Cohen’s d
zBMI	43	-0.97 (1.30)	48	-1.09 (1.47)	0.42 (ns)	0.08
%TGW	33	82.64 (8.47)	43	77.25 (9.21)	2.62 (.011)	0.61
Weight loss (kg)	29	13.33 (10.21)	39	13.93 (7.83)	0.27 (ns)	0.07
Symptom length (weeks)	37	44.60 (36.76)	40	38.90 (34.05)	0.71 (ns)	0.16
Rate (kg lost per week)	29	0.46 (0.33)	39	0.63 (0.54)	1.48 (ns)	0.36
RCADS (t-scores)
Depression	38	66.29 (19.05)	24	70.38 (15.76)	-0.88 (ns)	0.23
Generalized Anxiety	38	51.52 (15.34)	24	56.20 (14.81)	-1.18 (ns)	0.31
Obsessive/Compulsive	38	55.24 (17.41)	24	55.69 (13.86)	-0.11 (ns)	0.03
Panic	38	66.16 (22.78)	24	64.18 (22.40)	0.34 (ns)	0.09
Separation Anxiety	38	61.72 (20.88)	24	63.24 (16.07)	-0.30 (ns)	0.08
Social Phobia	38	57.63 (14.50)	24	62.23 (15.31)	-1.19 (ns)	0.31
Total Anxiety	38	60.69 (19.91)	24	63.21 (16.52)	-0.52 (ns)	0.14
Clinical Impairment from ED symptoms	38	24.02 (15.88)	24	30.63 (13.69)	-1.68 (.098)	0.44
Emotion Dysregulation	38	111.67 (30.78)	24	107.10 (29.93)	0.58 (ns)	0.15
EDEQ-A
Restraint	30	2.72 (2.12)	13	4.00 (1.78)	-1.90 (.065)	0.63
Eating Concerns	30	2.67 (1.96)	13	3.37 (1.08)	-1.48 (ns)	0.40
Shape Concerns	30	3.57 (2.34)	13	4.41 (1.86)	-1.14 (ns)	0.38
Weight Concerns	30	3.09 (2.19)	13	4.14 (1.83)	-1.52 (ns)	0.50
Total Score	30	3.01 (2.05)	13	3.98 (1.47)	-1.53 (ns)	0.51
chEAT	5	23.80 (17.50)	11	38.29 (17.91)	-1.51 (ns)	0.81

Notes. Mean scores and standard deviations are reported. %TGW, percent treatment goal weight; RCADS, Revised Children’s Anxiety and Depression Scale reported in t-scores; EDEQ-A, Eating Disorder Examination Questionnaire Adolescents; ChEAT, Children’s Eating Attitude Test.

Download PDF

Editorial decision: Major Revision
15 Mar, 2021
Review #1 received at journal
13 Mar, 2021
Review #4 received at journal
12 Mar, 2021
Review #3 received at journal
12 Mar, 2021
Review #2 received at journal
12 Mar, 2021
Reviewer #4 agreed at journal
19 Feb, 2021
Reviewer #3 agreed at journal
19 Feb, 2021
Reviewer #2 agreed at journal
18 Feb, 2021
Reviewer #1 agreed at journal
18 Feb, 2021
Reviews received at journal
18 Feb, 2021
Editor assigned by journal
17 Feb, 2021
Reviewers invited by journal
17 Feb, 2021
Submission checks completed at journal
17 Feb, 2021
Editor invited by journal
17 Feb, 2021
First submitted to journal
10 Feb, 2021

You are reading this latest preprint version

The Impact of COVID-19 on Adolescents with Eating Disorders: A Cohort Study

Status:

Version 1

Abstract

Plain English Summary

Background

Methods

Results

Discussion

Conclusion

Declarations

References

Tables

Status:

Version 1